Discovering the infectome of human endothelial cells challenged with Aspergillus fumigatus applying a mass spectrometry label-free approach

Journal of Proteomics

Volumn 97, Issue , 2014, Pages 126-140

  Curty, N ^a   Kubitschek Barreira, P H ^a   Neves, G W ^a   Gomes, D ^a   Pizzatti, L ^b   Abdelhay, E ^b   Souza, G H M F ^c   Lopes Bezerra, L M ^a  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b INSTITUTO NACIONAL DE CÂNCER   (Brazil)

^c WATERS CORPORATION   (United States)

Author keywords

A. fumigatus; Endothelial cell; HUVEC; Infectome; Invasive aspergillosis

Indexed keywords

AGRIN; AMINO ACID OXIDASE; CD51 ANTIGEN; CHROMODOMAIN HELICASE DNA BINDING PROTEIN 1 LIKE; COLLAGEN TYPE 5; COMPLEMENT COMPONENT C1R; CYCLIN DEPENDENT KINASE 3; DIS3 LIKE EXONUCLEASE 2; GLUTAMATE DEHYDROGENASE; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; INTERCELLULAR ADHESION MOLECULE 1; LAMIN B; LISTERINE; MAMMALIAN TARGET OF RAPAMYCIN; MULTIMERIN 1; MYOSIN I; MYOSIN VIIA; POLYADENYLATE BINDING PROTEIN 2; PROTEIN; RNA BINDING PROTEIN EWS; RNA BINDING PROTEIN RALY; SERINE PROTEINASE INHIBITOR E2; SYNTAXIN 12; TETRATRICOPEPTIDE REPEAT PROTEIN 27; THROMBOSPONDIN 2; TRANSFERRIN RECEPTOR PROTEIN 1; TYROSINE AMINOTRANSFERASE; UNCLASSIFIED DRUG;

ARTICLE; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; CELL VIABILITY; COMPUTER MODEL; FUNGUS GROWTH; HUMAN; HUMAN CELL; MASS SPECTROMETRY; MORPHOTYPE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEOMICS; UMBILICAL VEIN ENDOTHELIAL CELL; WESTERN BLOTTING;

ASPERGILLUS FUMIGATUS; FUNGI;

A. FUMIGATUS; ENDOTHELIAL CELL; HUVEC; INFECTOME; INVASIVE ASPERGILLOSIS; NANOLC-HDMS(E);

ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; HOST-PATHOGEN INTERACTIONS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MASS SPECTROMETRY; PROTEOME;

EID: 84892866985     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2013.07.003     Document Type: Article

References (45)

1. Bodey G.P., Vartivarian S. Aspergillosis. Eur J Clin Microbiol Infect Dis 1989, 8:413-437.
2. Fraser R.S. Pulmonary aspergillosis: pathologic and pathogenetic features. Pathol Annu 1993, 281:231-277.
3. Barth P.J., Rossberg C., Koch S., Ramaswamy A. Pulmonary aspergillosis in an unselected autopsy series. Pathol Res Pract 2000, 196:73-80.
4. Stevens D.A. Clinical aspergillosis for basic scientists. Med Mycol 2009, 47:S1-S4. (670).
5. Denning D.W. Invasive aspergillosis. Clin Infect Dis 1998, 26:781-805.
6. Singh N., Paterson D.L. Aspergillus infections in transplant recipients. Clin Microbiol Rev 2005, 18:44-69.
7. Maschmeyer G., Haas A., Cornely A. Invasive aspergillosis: epidemiology, diagnosis and management in immunocompromised patients. Drugs 2007, 67:1567-1601.
8. Filler S.G., Sheppard D.C. Fungal invasion of normally non-phagocytic. PLoS Pathog 2006, 2:e129.
9. Kamai Y., Lossinsky A.S., Liu H., Sheppard D.C., Filler S.G. Polarized response of endothelial cells to invasion by Aspergillus fumigatus. Cell Microbiol 2009, 11:170-182.
10. Shaukat A., Bakri F., Young P., Hahn T., Ball D., Baer M.R., et al. Invasive filamentous fungal infections inallogeneic hematopoietic stem cell transplant recipients after recovery from neutropenia: clinical, radiologic, and pathologic characteristics. Mycopathologia 2005, 159:181-188.
11. Lopes-Bezerra L.M., Filler S.G. Interactions of Aspergillus fumigatus with endothelial cells: internalization, injury, and stimulation of tissue factor activity. Blood 2004, 103:2143-2149.
12. Chiang L.Y., Sheppard D.C., Gravelat F.N., Patterson T.F., Filler S.G. Aspergillus fumigatusstimulates leukocyte adhesion molecules and cytokine production by endothelial cells in vitro and during invasive pulmonary disease. Infect Immun 2008, 76:3429-3438.
13. Jaffe E.A., Nachman R.L., Becker C.G., Minick C.R. Culture of human endothelial cells derived from umbilical veins: identification by morphologic and immunologic criteria. J Clin Invest 1973, 52:2745-2756.
14. Pizzatti L., Binato R., Cofre J., Gomes B.E., Dobbin J., Haussmann M.E., et al. SUZ12 is a candidate target of the non-canonical WNT pathway in the progression of chronic myeloid leukemia. Genes Chromosomes Cancer 2010, 49:107-118.
15. Denizot F., Lang R. Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods 1986, 89:271-277.
16. E. Proteomics 2011, 11:898-911.
17. Panis C., Pizzatti L., Herrera A.C., Cecchini R., Abdelhay E. Putative circulating markers of the early and advanced stages of breast cancer identified by high-resolution label-free proteomics. Cancer Lett 2013, 330:57-66.
18. Silva J.C., Denny R., Dorschel C.A., Gorenstein M., Kass I.J., Li G.Z., et al. Quantitative proteomic analysis by accurate mass retention time pairs. Anal Chem 2005, 77:2187-2200.
19. E. A virtue of parallel MS acquisition. Mol Cell Proteomics 2006, 5:144-156.
20. Geromanos S.J., Hughes C., Golick D., Ciavarini S., Gorenstein M.V., Richardson K., et al. Simulating and validating proteomics data and search results. Proteomics 2011, 11:1189-1211.
21. Li G.Z., Vissers J.P., Silva J.C., Golick D., Gorenstein M.V., Geromanos S.J. Database searching and accounting of multiplexed precursor and product ion spectra from the data independent analysis of simple and complex peptide mixtures. Proteomics 2009, 9:1696-1719.
22. Geromanos S.J., Johannes P.C., Vissers J.P., Silva J.C., Dorschel C.A., Li G.Z., et al. The detection correlation and comparison of peptide precursor and product ions from data independent LC-MS with data dependant LC-MS/MS. Proteomics 2009, 9:1683-1695.
23. Levin Y., Hradetzky E., Bahn S. Quantification of proteins using data-independent analysis (MSE) in simple and complex samples: a systematic evaluation. Proteomics 2011, 11:3273-3287.
24. Kaiser L., Sparks H.V.Jr Endothelial cells. Not just a cellophane wrapper. Arch Intern Med 1997, 147:569-573.
25. Zhang X., Wojcikiewicz E.P., Moy V.T. Dynamic adhesion of T lymphocytes to endothelial cells revealed by atomic force microscopy. Exp Biol Med 2006, 231:81306-81312.
26. Danese S., Dejana E., Fiocchi C. Immune regulation by microvascular endothelial cells: directing innate and adaptive immunity, coagulation, and inflammation. J Immunol 2007, 178:6017-6022.
27. Deng C., Zhang D., Shan S., Wu J., Yang H., Yu Y. Angiogenic effect of intercellular adhesion molecule-1. J Huazhong Univ Sci Technolog Med Sci 2007, 27:9-12.
28. Yoshida S., Ono M., Shono T., Izumi H., Ishibashi T., Suzuki H., et al. Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor α-dependent angiogenesis. Mol Cell Biol 1997, 17:4015-4023.
29. Seghezzi G., Patel S., Ren C.J., Gualandris A., Pintucci G., Robbins E.S., et al. Fibroblast growth factor-2 (FGF-2) induces vascular endothelial growth factor (VEGF) expression in the endothelial cells of forming capillaries: an autocrine mechanism contributing to angiogenesis. J Cell Biol 1998, 141:1659-1673.
30. Rusnati M., Camozzi M., Moroni E., Bottazzi B., Peri G., Indraccolo S., et al. Selective recognition of fibroblast growth factor-2 by the long pentraxin PTX3 inhibits angiogenesis. Blood 2004, 104:92-99.
31. Javerzat S., Franco M., Herbert J., Platonova N., Peille A.L., Pantesco V., et al. Correlating global gene regulation to angiogenesis in the developing chick extra-embryonic vascular system. PLoS One 2009, 4:e7856.
32. Ohneda O., Ohneda K., Arai F., Lee J., Miyamoto T., Fukushima Y., et al. ALCAM (CD166): its role in hematopoietic and endothelial development. Blood 2001, 98:2134-2142.
33. Bougatef F., Quemener C., Kellouche S., Naïmi B., Podgorniak M.P., Millot G., et al. EMMPRIN promotes angiogenesis through hypoxia-inducible factor-2alpha-mediated regulation of soluble VEGF isoforms and their receptor VEGFR-2. Blood 2009, 114:5547-5556.
34. Crosnier C., Bustamante L.Y., Bartholdson S.J., Bei A.K., Theron M., Uchikawa M., et al. Basigin is a receptor essential for erythrocyte invasion by Plasmodium falciparum. Nature 2011, 480:534-537.
35. Horiguchi H., Jin L., Ruebel K.H., Scheithauer B.W., Lloyd R.V. Regulation of VEGF-A, VEGFR-I, thrombospondin-1, -2, and -3 expression in a human pituitary cell line (HP75) by TGFbeta1, bFGF, and EGF. Endocrine 2004, 24:141-146.
36. Streit M., Stephen A.E., Hawighorst T., Matsuda K., Lange-Asschenfeldt B., Brown L.F., et al. Systemic inhibition of tumor growth and angiogenesis by thrombospondin-2 using cell-based antiangiogenic gene therapy. Cancer Res 2002, 62:2004-2012.
37. Ben-Ami R., Lewis R.E., Leventakos K., Kontoyiannis D.P. Aspergillus fumigatus inhibits angiogenesis through the production of gliotoxin and other secondary metabolites. Blood 2009, 114:5393-5399.
38. Kaneko Y., Kitazato K., Basaki Y. Integrin-linked kinase regulates vascular morphogenesis induced by vascular endothelial growth factor. J Cell Sci 2004, 117:407-415.
39. Jeimy S.B., Quinn-Allen M.A., Fuller N., Kane W.H., Hayward C.P. Location of the multimerin 1 binding site in coagulation factor V: an update. Thromb Res 2008, 123:352-354.
40. Beisswenger C., Hess C., Bals R. Aspergillus fumigatus conidia induceinterferon-β signaling in respiratory epithelial cells. Eur Respir J 2012, 39:408-411.
41. Biondo C., Midiri A., Gambuzza M., Gerace E., Falduto M., Galbo R., et al. IFNalpha/beta signaling is required for polarization of cytokine responses toward a protective type 1 pattern during experimental cryptococcosis. J Immunol 2008, 181:566-573.
42. Hatzoglou A., Roussel J., Bourgeade M.F., Rogier E., Madry C., Inoue J., et al. TNF receptor family member BCMA (B cell maturation) associates with TNF receptor-associated factor (TRAF) 1, TRAF2, and TRAF3 and activates NF-kappa B, elk-1, c-Jun N-terminal kinase, and p38 mitogen-activated protein kinase. J Immunol 2000, 165:1322-1330.
43. You Z., Ouyang H., Lopatin D., Polver P.J., Wang C.Y. Nuclear factor-kappa B-inducible death effector domain-containing protein suppresses tumor necrosis factor-mediated apoptosis by inhibiting caspase-8 activity. J Biol Chem 2001, 276:26398-26404.
44. Kirschnek S., Adams C., Gulbins E. Annexin II is a novel receptor for Pseudomonas aeruginosa. Biochem Biophys Res Commun 2005, 327:900-906.
45. Wang X.J., Zhu Y.J., Cui J.G., Huang X., Gu J., Xu H., et al. Proteomic analysis of human umbilical vein endothelial cells incubated with Cryptococcus neoformans var. neoformans. Mycoses 2011, 54:e336-e343.